Claim Verification: "Activation of cannabinoid receptor type 2 (CB2) on microglia has been proposed as a mechanism for modulating neuroinflammatory pain states, including chronic widespread pain syndromes such as fibromyalgia where central sensitization and microglial activation have been implicated (Cabral & Griffin-Thomas, 2009; Stella, 2010; Chen et al., 2023)." — Partially verified

Automated fact-verification of the claim: "Activation of cannabinoid receptor type 2 (CB2) on microglia has been proposed as a mechanism for modulating neuroinflammatory pain states, including chronic widespread pain syndromes such as fibromyalgia where central sensitization and microglial activation have been implicated (Cabral & Griffin-Thomas, 2009; Stella, 2010; Chen et al., 2023)." Verdict: PARTIALLY VERIFIED Files proof.py — Re-runnable Python verification script proof.md — Structured proof report proof_audit.md — Full verification audit trail proof_narrative.md — Plain-language summary proof.json — Machine-readable structured data Generated by Proof Engine v1.34.1.